Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cronos Group Inc (CRON)

Cronos Group Inc (CRON)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,311,464
  • Shares Outstanding, K 371,657
  • Annual Sales, $ 46,720 K
  • Annual Income, $ -73,140 K
  • 60-Month Beta 1.79
  • Price/Sales 69.69
  • Price/Cash Flow N/A
  • Price/Book 2.14
Trade CRON with:

Options Overview

Details
  • Implied Volatility 76.34%
  • Historical Volatility 72.28%
  • IV Percentile 30%
  • IV Rank 11.36%
  • IV High 274.66% on 10/02/20
  • IV Low 50.92% on 05/24/21
  • Put/Call Vol Ratio 0.18
  • Today's Volume 10,004
  • Volume Avg (30-Day) 16,404
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 183,546
  • Open Int (30-Day) 155,985

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.07
  • Number of Estimates 6
  • High Estimate -0.05
  • Low Estimate -0.10
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +63.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.00 +27.29%
on 05/13/21
9.42 -5.41%
on 06/09/21
+1.53 (+20.73%)
since 05/11/21
3-Month
6.99 +27.47%
on 05/11/21
10.94 -18.56%
on 03/16/21
-1.57 (-14.98%)
since 03/11/21
52-Week
4.91 +81.28%
on 10/02/20
15.83 -43.71%
on 02/10/21
+2.49 (+38.79%)
since 06/11/20

Most Recent Stories

More News
Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits

/PRNewswire/ -- Cannabidiol (CBD) extract is a product that's derived from cannabis. It's a type of cannabinoid, which are the chemicals naturally found in marijuana plants. Even though it comes from marijuana...

RTSL : 0.5500 (-3.51%)
TLRY : 19.89 (-0.80%)
TLRY.TO : 24.18 (-0.21%)
CRON : 8.91 (+1.71%)
CRON.TO : 10.82 (+2.08%)
ZYNE : 5.64 (+4.06%)
IGC : 1.4900 (unch)
Four Cannabis Stocks for the Summer of 2021

Cannabis stocks have staged a rousing return in recent weeks after a quiet first half of 2021. Sales are on the rise this year as revenue and profits for many cannabis companies have increased significantly....

TLRY : 19.89 (-0.80%)
PHCG : 0.4500 (-2.17%)
CRON : 8.91 (+1.71%)
XXII : 4.79 (+3.68%)
Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell...

CRON : 8.91 (+1.71%)
CRON.TO : 10.82 (+2.08%)
Delivery Service Market is One of the Hottest Revenue Streams In Cannabis Industry

, /PRNewswire/ -- Over the past few years the legalization of marijuana has spurred the industry's growth in both medicinal and recreational markets and the growth appears that it will continue to substantially...

NXGB : 0.3100 (-6.03%)
OGI : 3.18 (+0.63%)
OGI.TO : 3.87 (+1.31%)
CRON : 8.91 (+1.71%)
CRON.TO : 10.82 (+2.08%)
ACB : 9.82 (-0.71%)
ACB.TO : 11.94 (-0.33%)
HEXO : 6.62 (+0.30%)
HEXO.TO : 8.02 (+0.12%)
Markets Close Flat, Await New Jobs Data

Tomorrow brings us our first steady diet of useful economic data of the week, with both normal Thursday Initial Jobless Claims and ADP (ADP) private-sector payrolls.

AMZN : 3,346.83 (-0.08%)
ADP : 199.65 (-0.20%)
BBY : 114.45 (+1.70%)
PETS : 32.82 (+0.21%)
PVH : 113.04 (+3.97%)
AMC : 49.40 (+15.39%)
CRON : 8.91 (+1.71%)
TLRY : 19.89 (-0.80%)
There is a Growing Need for Innovative Devices to Stifle Cannabis Misuse

, /PRNewswire/ -- While the pandemic has been terrible for many industries and businesses, the cannabis market turned out to be an unexpected winner. In 2020, legal cannabis sales in the U.S were up 46%...

CRLBF : 11.4700 (-1.29%)
BLOZF : 0.8979 (-0.24%)
BLO.CN : 1.080 (-0.92%)
CRON : 8.91 (+1.71%)
HEXO : 6.62 (+0.30%)
OGI : 3.18 (+0.63%)
CL.CN : 13.960 (-0.71%)
Cronos (CRON) Moves 15.2% Higher: Will This Strength Last?

Cronos (CRON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

CRON : 8.91 (+1.71%)
The Miracle Compound Tackling A Trillion Dollar Crisis

, /PRNewswire/ -- Today, the world seeing the beginning of the next great biotech boom... and it has nothing to do with COVID-19. Thanks to new laws sweeping , there might be a groundbreaking new opportunity...

ACB.TO : 11.94 (-0.33%)
TLRY : 19.89 (-0.80%)
CRON : 8.91 (+1.71%)
ACB : 9.82 (-0.71%)
CGC : 25.87 (+0.82%)
Cronos Group Inc. to Participate in Canaccord Genuity's 5th Annual Global Cannabis Conference on May 11, 2021

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at Canaccord...

CRON : 8.91 (+1.71%)
CRON.TO : 10.82 (+2.08%)
Cronos Group Launches Marketing Code to Drive Responsibility Within the Cannabis Industry

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") today released a Marketing Code designed to responsibly move the emerging cannabis industry forward. Cronos Group believes...

CRON : 8.91 (+1.71%)
CRON.TO : 10.82 (+2.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as...

See More

Key Turning Points

3rd Resistance Point 9.24
2nd Resistance Point 9.09
1st Resistance Point 9.00
Last Price 8.91
1st Support Level 8.76
2nd Support Level 8.61
3rd Support Level 8.52

See More

52-Week High 15.83
Fibonacci 61.8% 11.66
Fibonacci 50% 10.37
Fibonacci 38.2% 9.08
Last Price 8.91
52-Week Low 4.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar